NAMSW

100.00% -20.07

Dopo l'orario di chiusura: 20.07 20.07 +

Newamsterdam Pharma Company N V (NAMSW)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Newamsterdam Pharma Company N V Stock (NAMSW) Company Profile

Newamsterdam Pharma Company N V

Healthcare (1112)

Biotechnology (620)

31 35 206 2971

Gooimeer 2-35, Naarden

Prossima data di guadagno

Ultimi documenti SEC

NAMSW's Discussions on Twitter

Compare NAMSW vs VRTX, REGN, ARGX, ALNY, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
NAMSW Newamsterdam Pharma Company N V	0.00	0	0	0	0	0.00
VRTX Vertex Pharmaceuticals Inc	433.07	110.01B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	737.71	77.99B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	691.40	42.91B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	317.36	42.09B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	283.03	31.42B	5.36B	287.73M	924.18M	2.5229

Newamsterdam Pharma Company N V Borsa (NAMSW) Ultime notizie

Newamsterdam Pharma Company N V Azioni (NAMSW) Dati Finanziari

Non sono disponibili dati finanziari per Newamsterdam Pharma Company N V (NAMSW). Controlla altri titoli per ulteriori informazioni.

Newamsterdam Pharma Company N V (NAMSW)

Newamsterdam Pharma Company N V Stock (NAMSW) Company Profile

Compare NAMSW vs VRTX, REGN, ARGX, ALNY, ONC

Newamsterdam Pharma Company N V Borsa (NAMSW) Ultime notizie

Upcoming Obicetrapib Phase 3 Data at ACC.26 Might Change The Case For Investing In NewAmsterdam Pharma (NAMS) - Yahoo Finance

Behavioral Patterns of NAMSW and Institutional Flows - Stock Traders Daily

NewAmsterdam Pharma Announces Three Presentations at the 2026 American College of Cardiology Annual Scientific Session - The Manila Times

A cholesterol pill's kidney and safety data head to a major heart meeting - Stock Titan

JPMorgan Chase & Co. Trims Stock Position in NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Earnings Update: How does NewAmsterdam Pharma Company NV Equity Warrant compare to its peersGap Up & Long Hold Capital Preservation Plans - baoquankhu1.vn

Does NewAmsterdam Pharma Company NV have declining or rising EPSEarnings Beat & AI Forecasted Stock Moves - baoquankhu1.vn

NAMS SEC FilingsNewAmsterdam Pharma Company N.V 10-K, 10-Q, 8-K Forms - Stock Titan

(NAMS) Risk Channels and Responsive Allocation - Stock Traders Daily

Why is NewAmsterdam Pharma Company NV stock going downIPO Watch & Daily Oversold Bounce Ideas - baoquankhu1.vn

Truist initiates NewAmsterdam Pharma stock coverage with buy rating By Investing.com - Investing.com South Africa

Truist initiates NewAmsterdam Pharma stock coverage with buy rating - Investing.com

Published on: 2026-03-19 02:35:41 - baoquankhu1.vn

NewAmsterdam Pharma Company N.V. $NAMS Shares Sold by Fcpm Iii Services B.V. - MarketBeat

NewAmsterdam Pharma Company N.V. $NAMS is Decheng Capital LLC's 5th Largest Position - MarketBeat

ArrowMark Colorado Holdings LLC Has $8.85 Million Holdings in NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat

NAMSW SEC FilingsNewAmsterdam Pha 10-K, 10-Q, 8-K Forms - Stock Titan

(NAMSW) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

Gains Report: Why is NewAmsterdam Pharma Company NV stock going down2026 Spike Watch & Daily Technical Stock Forecast Reports - baoquankhu1.vn

NewAmsterdam Pharma (NASDAQ:NAMS) Director Sells $1,357,309.98 in Stock - MarketBeat

Insider Sell: Louis Lange Sells 44,619 Shares of NewAmsterdam Ph - GuruFocus

NewAmsterdam Pharma Director Sells Shares - TradingView

Director at NewAmsterdam Pharma (NAMS) sells 44,619 shares - Stock Titan

NewAmsterdam Pharma Company N.V. $NAMS Shares Acquired by Capital World Investors - MarketBeat

Warrant exercise and trust sale at NewAmsterdam Pharma (NASDAQ: NAMS) - Stock Titan

NewAmsterdam Pharma Company N.V. $NAMS Shares Bought by American Century Companies Inc. - MarketBeat

Louis Lange Sells 28,186 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) Stock - MarketBeat

NewAmsterdam Pharma (NAMS) director exercises 44,619 warrants as trust sells 28,186 shares - Stock Titan

NewAmsterdam Pharma (NASDAQ:NAMS) CEO Sells $14,753,257.75 in Stock - MarketBeat

Insider Selling: NewAmsterdam Pharma (NASDAQ:NAMS) Insider Sells $3,165,350.10 in Stock - MarketBeat

Johannes Jacob Piete Kastelein Sells 101,409 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) Stock - MarketBeat

(NAMS) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Trend Report: Is NewAmsterdam Pharma Company NV Equity Warrant stock trending bullishMarket Performance Summary & Daily Technical Forecast Reports - baoquankhu1.vn

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

NewAmsterdam Pharma gives two new hires 10K options, 2,200 RSUs - Stock Titan

Stock Recap: Is NewAmsterdam Pharma Company NV Equity Warrant stock trending bullish2025 Technical Patterns & Smart Money Movement Tracker - baoquankhu1.vn

Insider Selling: NewAmsterdam Pharma (NASDAQ:NAMS) CEO Sells $14,753,257.75 in Stock - Defense World

[144] NewAmsterdam Pharma Co N.V. SEC Filing - Stock Titan

NewAmsterdam Pharma Hits Day Low at $30.20 Amid Price Pressure - marketsmojo.com

NewAmsterdam Pharma (NAMS) Stock Analysis: Exploring a 46.68% Potential Upside Amidst Strong Buy Ratings - DirectorsTalk Interviews

NewAmsterdam Pharma CEO Sells Over $14 Million in Shares - TradingView

NewAmsterdam Pharma (NAMS) CEO sells 443,707 shares after option exercise - Stock Titan

NewAmsterdam Pharma (NASDAQ: NAMS) files Form 144 to sell 443,707 shares - Stock Titan

NewAmsterdam Pharma (NASDAQ:NAMS) Sees Large Volume IncreaseStill a Buy? - MarketBeat

NewAmsterdam Highlights Obicetrapib Progress in Investor Presentation - TipRanks

NewAmsterdam posts updated investor presentation highlighting obicetrapib efficacy, safety, IP and cash runway - TradingView

Obicetrapib data and AD signals in NewAmsterdam (NAMS) deck - Stock Titan

Handelsbanken Fonder AB Boosts Stake in NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat

NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in March - Sahm

JPMorgan Chase & Co. Has $37.04 Million Position in NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat

Newamsterdam Pharma Company N V Azioni (NAMSW) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a NAMSW